Literature DB >> 20477994

Angiographic assessment of cardiac allograft vasculopathy: results of a Consensus Conference of the Task Force for Thoracic Organ Transplantation of the German Cardiac Society.

Ernst Wellnhofer1, Jörg Stypmann, Christoph L Bara, Thomas Stadlbauer, Martin C Heidt, Hans U Kreider-Stempfle, Hae-Young Sohn, Wolfgang Zeh, Thomas Comberg, Siegfried Eckert, Thomas Dengler, Stephan M Ensminger, Nicola E Hiemann.   

Abstract

Angiograms of cardiac transplant (HTx) recipients were to be evaluated in a ring experiment and a joint consensus on criteria of angiographic evaluation of coronary arteries of HTx patients was to be reached. Twenty-four coronary angiograms from 11 hospitals were circulated. One hundred eighty-eight blinded evaluations were returned. A joint evaluation by six experienced cardiologists was used as reference standard and a consensus evaluation form was developed. Significant lesions (stenosis 75%, 50% in the left main coronary artery) were diagnosed in 10/23 abnormal coronary angiograms (41.7%). Interventional revascularization was recommended in 8/10 (80%). In 21 coronary angiograms distal pruning was found and in 11/21 (52.4%) cases with distal pruning occlusion of at least one peripheral vessel was detected. The best kappa value (0.7) was found for the presence of at least one clinically significant stenosis. Agreement on the site and grade of local stenosis was much less. Some agreement on remodeling was found in assessing diffuse narrowing in the LCA (kappa=0.371, P<0.001). The kappa value for peripheral obliteration was 0.331 (P=0.001). Angiographic evaluation of cardiac allograft vasculopathy, particularly of diffuse and peripheral disease and remodeling, needs standardization. This should be performed in a downward compatible improvement process.
© 2010 The Authors. Journal compilation © 2010 European Society for Organ Transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20477994     DOI: 10.1111/j.1432-2277.2010.01096.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

1.  Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.

Authors:  Travis B DeSa; Muhannad A Abbasi; Julie A Blaisdell; Kai Lin; Jeremy D Collins; James C Carr; Michael Markl
Journal:  Clin Imaging       Date:  2019-12-19       Impact factor: 1.605

Review 2.  [Heart transplantation. Pathology, clinical work-up and therapy].

Authors:  H A Baba; J Wohlschläger; J Stypmann; N E Hiemann
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

3.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

4.  Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.

Authors:  Miguel Hernandez Pampaloni; Uttam M Shrestha; Maria Sciammarella; Youngho Seo; Grant T Gullberg; Elias H Botvinick
Journal:  J Nucl Cardiol       Date:  2017-01-30       Impact factor: 5.952

5.  Inhomogeneous myocardial stress perfusion in SPECT studies predicts future allograft dysfunction in heart transplant recipients.

Authors:  Christian Wenning; Alexis Vrachimis; Angelo Dell Aquila; Alvyda Penning; Jörg Stypmann; Michael Schäfers
Journal:  EJNMMI Res       Date:  2015-10-05       Impact factor: 3.138

Review 6.  Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.

Authors:  Boško Skorić; Maja Čikeš; Jana Ljubas Maček; Željko Baričević; Ivan Škorak; Hrvoje Gašparović; Bojan Biočina; Davor Miličić
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

7.  Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.

Authors:  Nazia Husain; Kae Watanabe; Haben Berhane; Aditi Gupta; Michael Markl; Cynthia K Rigsby; Joshua D Robinson
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-22       Impact factor: 5.364

8.  Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82Rb PET.

Authors:  Uttam M Shrestha; Maria Sciammarella; Miguel Hernandez Pampaloni; Elias H Botvinick; Grant T Gullberg; Teresa DeMarco; Youngho Seo
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-29       Impact factor: 2.357

9.  Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.

Authors:  Sakura Nagumo; Emanuele Gallinoro; Alessandro Candreva; Takuya Mizukami; Giovanni Monizzi; Monika Kodeboina; Sofie Verstreken; Riet Dierckx; Ward Heggermont; Jozef Bartunek; Marc Goethals; Dimitri Buytaert; Bernard De Bruyne; Jeroen Sonck; Carlos Collet; Marc Vanderheyden
Journal:  J Interv Cardiol       Date:  2020-07-12       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.